Cell viability assays, which were conducted with triple-negative breast cancer (TNBC) cell lines harboring PIK3CA hotspot mutations, demonstrated a significant reduction in the proportion of early cell apoptosis in the PIK3CA mutant group compared to the PIK3CA wild-type group (p = 0.04) [22]. This evidence concerns the gene PIK3CA and triple-negative breast carcinoma.